Treatment for leukemia has improved remarkably during the past few decades as more patients are surviving and thriving following a leukemia diagnosis. Patients who come to the University of Chicago Medicine for leukemia care have access to the most advanced treatments, including:

  • Targeted therapies (for some types of leukemia) that specifically attack the molecular abnormalities that cause cancers of the blood
  • The most recent approaches in chemotherapy
  • Immunotherapies, which stimulate or train the immune system to attack and eradicate leukemia cells.
  • We’re among just a few centers in the country offering CAR T-cell therapy, a new type of immunotherapy that shows promise for patients with acute lymphoblastic leukemia and other blood cancers.
  • Comprehensive blood and bone marrow stem cell transplantation, including unrelated donor and cord blood transplants, which make these life-saving procedures a possibility for more patients. UChicago Medicine had the best one-year stem cell transplant outcomes in Chicago and the highest relative to predicted outcomes, according to a 2020 annual report from the Center for International Bone and Marrow Transplant Research. Learn about our work to improve stem cell transplant survival rates.
  • Supportive therapies to help reduce fatigue, infections and other problems that may develop due to leukemia or leukemia treatments
  • Clinical trials of new treatments for leukemia and myelodysplastic syndromes, including early Phase I trials and studies not widely available
car t-cell therapy

CAR T-Cell Therapy

CAR T-cell therapy supercharges a patient's white blood cells to find and destroy cancer cells. UChicago Medicine research played a key role in the development of this exciting new immunotherapy.

View videos and learn more